Apellis Pharmaceuticals, Inc.
2023 Q3 - 2026 Q1 (11 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2026 Q1 | 4/22/2026 | 7,561 | 0.0% | 426,821 | 3/31/2026 |
| 2025 Q4 | 1/29/2026 | 9,838 | 0.0% | 390,884 | 12/31/2025 |
| 2025 Q3 | 11/18/2025 | 8,232 | 0.0% | 363,450 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 6,071 | 0.0% | 348,349 | 6/30/2025 |
| 2025 Q1 | 5/5/2025 | 7,618 | 0.0% | 314,842 | 3/31/2025 |
| 2024 Q4 | 2/12/2025 | 11,100 | 0.0% | 347,854 | 12/31/2024 |
| 2024 Q3 | 11/12/2024 | 8,775 | 0.0% | 297,953 | 9/30/2024 |
| 2024 Q2 | 8/13/2024 | 9,707 | 0.0% | 253,048 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 63,032 | 0.1% | 1,073,234 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 80,486 | 0.1% | 1,344,563 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 27,927 | 0.0% | 734,150 | 9/30/2023 |